Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian prostate cancer group study number 6

P Iversen; JE Johansson; P Lodding; O Lukkarinen; P Lundmo; P Klarskov; TJL Tammela; I Tasdemir; T Morris; K Carroll

Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian prostate cancer group study number 6

P Iversen
, JE Johansson
, P Lodding
, O Lukkarinen
, P Lundmo
, P Klarskov
, TJL Tammela
, I Tasdemir
, T Morris
, K Carroll

Research output: Contribution to journal › Article › Scientific › peer-review

97 Citations (Scopus)

Original language	English
Pages (from-to)	1871-1876
Journal	Journal of Urology
Volume	172
Publication status	Published - 2004
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Iversen, P., Johansson, JE., Lodding, P., Lukkarinen, O., Lundmo, P., Klarskov, P., Tammela, TJL., Tasdemir, I., Morris, T., & Carroll, K. (2004). Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian prostate cancer group study number 6. Journal of Urology, 172, 1871-1876.

@article{6f01b0abb04844a3945f7aa46af10617,

title = "Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian prostate cancer group study number 6",

author = "P Iversen and JE Johansson and P Lodding and O Lukkarinen and P Lundmo and P Klarskov and TJL Tammela and I Tasdemir and T Morris and K Carroll",

year = "2004",

language = "English",

volume = "172",

pages = "1871--1876",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Wolters Kluwer Health",

}

Iversen, P, Johansson, JE, Lodding, P, Lukkarinen, O, Lundmo, P, Klarskov, P, Tammela, TJL, Tasdemir, I, Morris, T & Carroll, K 2004, 'Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian prostate cancer group study number 6', Journal of Urology, vol. 172, pp. 1871-1876.

Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian prostate cancer group study number 6. / Iversen, P; Johansson, JE; Lodding, P et al.
In: Journal of Urology, Vol. 172, 2004, p. 1871-1876.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian prostate cancer group study number 6

AU - Iversen, P

AU - Johansson, JE

AU - Lodding, P

AU - Lukkarinen, O

AU - Lundmo, P

AU - Klarskov, P

AU - Tammela, TJL

AU - Tasdemir, I

AU - Morris, T

AU - Carroll, K

PY - 2004

Y1 - 2004

M3 - Article

SN - 0022-5347

VL - 172

SP - 1871

EP - 1876

JO - Journal of Urology

JF - Journal of Urology

ER -